Samuel Blackman
Founder presso DAY ONE BIOPHARMACEUTICALS, INC.
Patrimonio netto: 36 M $ in data 31/03/2024
Profilo
Samuel C.
Blackman is the founder of Day One Biopharmaceuticals, Inc. where he currently holds the title of Head-Research & Development since 2023.
He is also the founder of DOT Therapeutics-2, Inc. Dr. Blackman's former job positions include Senior Medical Director at Juno Therapeutics, Inc. from 2014 to 2016, Head-Clinical Development at Silverback Therapeutics, Inc. from 2016 to 2018, and Head-Clinical Development at Mavupharma, Inc. from 2018 to 2019.
Dr. Blackman's education includes undergraduate and doctorate degrees from the University of Illinois.
Dr. Blackman is also the founder of DOT Therapeutics-2, Inc...
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 25/03/2024 | 2 184 662 ( 2.50% ) | 36 M $ | 31/03/2024 |
Posizioni attive di Samuel Blackman
| Società | Posizione | Inizio |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Founder | 01/11/2018 |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Founder | - |
Precedenti posizioni note di Samuel Blackman
| Società | Posizione | Fine |
|---|---|---|
Mavupharma, Inc.
 Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Corporate Officer/Principal | 01/07/2019 |
| ARS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2018 |
| JUNO THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 01/08/2016 |
Formazione di Samuel Blackman
| University of Illinois | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
Mavupharma, Inc.
Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Health Technology |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Health Technology |
| Day One Biopharmaceuticals, Inc. |
- Borsa valori
- Insiders
- Samuel Blackman
